Completed PHASE3 INTERVENTIONAL 4-arm NCT00864331

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

Sponsor: International Atomic Energy Agency

Interventions Chemotherapy Chemotherapy and radiotherapy Palliative radiotherapy and chemotherapy radiation

Updated 6 times since 2017 Last updated: Aug 6, 2013 Started: Feb 29, 2008 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Non Small Cell Lung Cancer, this trial is completed. The trial is conducted by International Atomic Energy Agency and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Study Description(click to expand)

To compare survival rates (median and 1-year), and toxicity of two treatment regimens in patients with locally advanced incurable NSCLC (study A), to compare survival rates (median and 1-year) of two treatment regimens in patients with locally advanced and metastatic NSCLC (study B) To compare HRQoL and cost effectiveness of two treatment regimens in patients with locally advanced incurable NSCLC (study A), and in patients with locally advanced and metastatic NSCLC (study B) and to evaluate the effect of HRQoL assessment on QoL dimensions

To compare HRQoL and cost effectiveness of two treatment regimens in patients with locally advanced incurable NSCLC (study A), and in patients with locally advanced and metastatic NSCLC (study B) and to evaluate the effect of HRQoL assessment on QoL dimensions

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Atomic Energy Agency

Data source: International Atomic Energy Agency

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Cairo, Egypt , Floriana, Malta , Islamabad, Pakistan , Johannesburg, South Africa , Kuala Lumpur, Malaysia , Lima, Peru , Mumbai, India , Panama City, Panama , Rabat, Morocco , Santiago, Chile and 3 more locations